Meningococcal Disease Completed Phase 2 Trials for Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583)

IndicationStatusPhase
DBCOND0033309 (Meningococcal Disease)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00661557Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-vaccinated SubjectsPrevention
NCT00488683B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy InfantsPrevention